Topline data were announced from a phase 3b trial evaluating the concomitant use of ixekizumab and tirzepatide in adults with active psoriatic arthritis and obesity.

Pregnant women with SpA face an increased risk of delivering SGA infants, while most other pregnancy outcomes appear comparable to the general population.

The CDC revised the pediatric vaccine schedule based on international standards, though the American Academy of Pediatrics ...

For those looking to lower stress levels this year, hitting the gym or walking might be the best strategy, especially for women.

Novo Nordisk announced the availability of Wegovy tablets, the first oral GLP-1 receptor agonist for weight loss and CV risk reduction.

Children conceived via assisted reproductive technology (ART) have a higher risk for developing atopic disease.

Topline data were announced from two phase 3 studies evaluating setrusumab in patients with osteogenesis imperfecta.

Tea consumption is associated with higher total hip BMD in older women, while excessive coffee intake may adversely affect ...

Which of the statements about the 2025 American College of Rheumatology guideline for the treatment of systemic lupus ...

Topline data were announced from the phase 3 INDIGO trial evaluating obexelimab in adults with immunoglobulin G4-related disease.

Phase 3 trial data show subcutaneous anifrolumab improves BICLA response rates and reduces oral corticosteroid use in systemic lupus erythematosus.

Higher pulse pressure was associated with greater progression of weight-bearing knee pain among adults with or at risk for knee OA.